Q2 2010

Filed Aug 16, 2010 · 10-Q · 47 days after period end · 0001144204-10-044863

Q2 2010 · 10-Q

Revenue

$10.81M

no prior Q2 2009 on file

Net Income

-$4.49M

no prior Q2 2009 on file

EPS Diluted

-$0.86

no prior Q2 2009 on file

Operating Income-$4,488,000—

Margins · derived

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 16, 2010 · 47 d after period end

Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR